Health House International Ltd (hhi) Logo

Health House International Ltd (HHI)

___:___ · Healthcare
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

HHI Chart

Snapshot

HHI's Principal Activity is the provision of a cloud-based video e-learning software platform (Learning Management System or LMS) and a brand technology agency (Consulting Services); Realising assets, winding down operations of its former businesses and seeking new investment opportunities.

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2022 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) -91.50%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 2,389 of 2,416
Sector Rank 206 of 210

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies JTL / MGZ / 1ST
EPS -$0.114
DPS $0.00
Book Value Per Share $0.04

Broker Consensus

HHI is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Date Heading Pages File Size Time

Corporate Overview

Health House International Limited (HHI) is an international pharmaceutical distributor specialising in, but not limited to, the distribution of medicinal cannabis products across Australasia, United Kingdom and Europe.

Incorporation Details

No incorporation details available.

Corporate Details

Head Office Perth WA 6000
Website www.healthhouse.com.au
Registry Link Market Services
Auditor HLB Mann Judd (WA Partnership)
Date Listed 28 Jul 2011

Upcoming Calendar (Forecasted)

Date Event
31/08/2022 Report (Prelim)
30/09/2022 Report (Annual)
28/02/2023 Report (Interim)

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors & Management

Name Title Since Bio
Dr Henrik Sprengel Executive Director Aug 2021

Dr Henrik Sprengel

Executive Director

Dr Sprengel is co-founder of both CanPharma and Kalapa Clinic where he has gained experience in the field of medicinal cannabis. He is currently CEO of CanPharma. Before founding CanPharma, he was CEO of the company builder Grupo HS3, which launched several international projects across a number of industries, with a focus on internet and technology. Henrik started his career as a lawyer at Clifford Chance; he later held several international senior management positions in global media company Bertelsmann, and as country manager for Spain and Mexico for a German media and tech company.

Mr David Attwood Chief Executive Officer Aug 2021
Mr David Colin Wheeler Non-Executive Chairman,Non-Executive Director Mar 2021

Mr David Colin Wheeler

Non-Executive Chairman,Non-Executive Director

Mr Wheeler has more than 30 years executive management experience, through general management, CEO and Managing Director roles across a range of companies and industries. He has worked on business projects in the USA, UK, Europe, New Zealand, China, Malaysia, and the Middle East (Iran).

Hon Michael Rann Non-Executive Director Mar 2021

Hon Michael Rann

Non-Executive Director

Mr Rann served as a politician in Australia for 26 years where he held roles dealing with both national and international relations which included his ambassador roles to the UK and Italy. Mr Rann now resides in London / Italy where he is the Chairman of the UK registered charity The Power of Nutrition, and is a member of the UK, US and Global boards of London headquartered The Climate Group. He is a Visiting Professor at the Policy Institute of King's College London. He also holds the positions of CEO to his London based business consultancy, Rann Strategy Group

Mr Timothy (Tim) Ryan Slate Company Secretary Mar 2021
Mr Christopher (Chris) Lee Mews Non-Executive Director Jul 2018

Mr Christopher (Chris) Lee Mews

Non-Executive Director

Mr Mews has been in financial services for over 20 years and is experienced in the financial operation, governance and compliance of Managed Investment Schemes, ASX listed companies and unlisted companies. Mr Mews has held senior positions in finance, corporate secretarial and compliance. In these roles he has been a member of senior management and participated in the due diligence and acquisition of Managed Investment Schemes and participated in various capital raisings for Managed Investment Schemes, ASX listed companies and unlisted companies

Director Transactions

HHI directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
19/03/21 David Wheeler Issued 20,000 $0.20 $4,000 Issue of securities
19/03/21 David Wheeler Buy +4,965,929 $0.20 $993,186 As advised by the company
19/03/21 David Wheeler Buy +1 $0.00 $0 As advised by the company
19/03/21 Leanne Graham Transfer 13,333 $0.004 $53 Off-market transfer
19/03/21 Leanne Graham Transfer 13,333 $0.004 $53 Off-market transfer

Director Interests

The current holdings of HHI directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Henrik Sprengel 10/08/2021 5,816,250 N/A N/A N/A
Michael Rann 30/06/2021 226,085 N/A N/A N/A
David Wheeler 30/06/2021 1 4,985,929 N/A N/A
Christopher (Chris) Mews 30/06/2021 N/A 12,500 N/A N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Sep 21, 2021.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Cityscape Asset Pty Ltd <Cityscape Family A/C> 13,459,365 7.59%
New Frontier Pty Ltd 11,161,239 6.29%
Gemelli Nominees Pty Ltd <Gemelli Family A/C> 10,558,085 5.95%
Henrik Sprengel 5,816,250 3.28%
Pathways Corp Investments Pty Ltd <The Pc Investments Account> 4,885,929 2.76%
The Trust Company (Australia) Limited <Mof A/C> 4,000,000 2.26%
Pekse Pty Ltd <The Pekse A/C> 2,663,032 1.50%
Keryn Lee Reynolds 2,663,032 1.50%
Dozemei Pty Ltd <La Repubblica Venexiana A/C> 2,500,000 1.41%
Goldney Pty Ltd <Blackman Mutual A/C> 2,141,622 1.21%
Mr John Murphy 2,000,000 1.13%
Tisia Nominees Pty Ltd <Henderson Family A/C> 1,901,754 1.07%
Stefan Jacker 1,797,030 1.01%
Silver Birch Capital Corporation 1,762,301 0.99%
Holger Sprengel 1,712,340 0.97%
The Trust Company (Australia) Limited <Mof> 1,650,000 0.93%
David Attwood 1,608,660 0.91%
Kurt Sprengel 1,502,820 0.85%
Mr Jacob Kai Murphy 1,500,000 0.85%
Mr Joshua Murphy 1,500,000 0.85%

Shareholder Distribution

As reported in the most recent Annual Report.

The most recent Annual Report didn't contain Shareholder Distribution data.

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Name Last Notice Total Shares Shares Held (%)
Jason Peterson 21/09/2021 17,336,651 9.77
New Frontier Pty Ltd 21/09/2021 11,161,239 6.29
Gemelli Nominees Pty Ltd 21/09/2021 10,558,085 5.95

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2021 $0.14 30 June
HHI Historical Price Data (CSV)
Up to 20 years of EOD share price history
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.